The long-term investor command center. One ticker, the whole case — a Quality / Value / Momentum / Smart-Money read on top of valuation-in-context, ROIC & moat, dividend health, trend, financial health, and who’s buying. Built only from SEC filings and end-of-day prices. Glass-box, no invented numbers.
Free to use. No account, no card.
Building TOVX’s long-term case…
Pulling SEC filings
Parsing XBRL fundamentals
Scoring quality, value & momentum
Checking who’s buying
Rendering
TOVX
Theriva Biologics, Inc.Small cap · $8.4M · FY ending 2011-12-31
filingAcquisition or disposition completed8-K accepted 4:05 p.m. ET on Nov 2, after the close · source →
Educational tools — not financial advice. Fundamentals from SEC EDGAR (XBRL); prices are end-of-day (Databento). Scores are a transparent blend of the components shown, computed on our own data — a research aid, not a recommendation.